Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 3, 2010, Pages 1207-1219

  Zemskova, Marina S ^a   Gundabolu, Bhaskar ^a   Sinaii, Ninet ^b   Chen, Clara C ^c   Carrasquillo, Jorge A ^c   Whatley, Millie ^c   Chowdhury, Iffat ^a   Gharib, Ahmed M ^b   Nieman, Lynnette K ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; CARBIDOPA; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; PENTETATE INDIUM IN 111;

ABDOMEN; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG DOSE COMPARISON; DRUG MEGADOSE; ECTOPIC ACTH SECRETING TUMOR; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; HUMAN; IMAGING SYSTEM; LOW DRUG DOSE; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NECK; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX; TUMOR; TUMOR DIAGNOSIS;

EID: 77749270829     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2282     Document Type: Article

References (25)

1. Lindsay JR, Nieman LK 2005 Differential diagnosis and imaging in Cushing's syndrome. Endocrinol Metab Clin North Am 34:403-421, x
2. Newell-Price J, Bertagna X, Grossman AB, Nieman LK 2006 Cushing's syndrome. Lancet 367:1605-1617
3. Wajchenberg BL, Mendonca BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A, Kirschner MA 1994 Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 15:752-787
4. Findling JW, Tyrrell JB 1986 Occult ectopic secretion of corticotropin. Arch Intern Med 146:929-933
5. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK 2005 Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 90:4955-4962
6. Limper AH, Carpenter PC, Scheithauer B, Staats BA 1992 The Cushing syndrome induced by bronchial carcinoid tumors. Ann Intern Med 117:209-214
7. Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, Jenkins PJ, Monson JP, Grossman AB, Besser GM 2006 The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 91:371-377
8. Doppman JL, Nieman L, Miller DL, Pass HI, Chang R, Cutler Jr GB, Schaaf M, Chrousos GP, Norton JA, Ziessman HA, Oldfield EH, Loriaux DL 1989 Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients. Radiology 172:115-124
9. Papotti M, Croce S, Bello M, Bongiovanni M, Allia E, Schindler M, Bussolati G 2001 Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy. Virchows Arch 439:787-797
10. McCarthy KE, Espenan GD, Cronin M, Anthony LB, Woltering EA 1998 Visualization of somatostatin receptor-positive lesions with 111-In-pentetreotide is dose dependent. Dig Dis Sci 43:1876
11. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PP, Lamberts SW 1993 Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 20:283-292
12. Kumar J, Spring M, Carroll PV, Barrington SF, Powrie JK 2006 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours. Clin Endocrinol (Oxf) 64:371-374
13. 111In]-diethylenetriaminepentaacetate-D-Phe- pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin- secreting tumors causing Cushing's syndrome. J Clin Endocrinol Metab 89:2214-2221
14. 111In-pentetreotide negative GEP tumours. Nucl Med Commun 28:473-477
15. 18F-DOPA) positron emission tomography as a tool to localize an insulinoma or β-cell hyperplasia in adult patients. J Clin Endocrinol Metab 92:1237-1244
16. 18F-DOPA PET/CT and neuroendocrine tumours. Eur J Nucl Med Mol Imaging 33:509-513
17. Newcombe RG 1998 Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857-872
18. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler Jr GB, Loriaux DL 1991 Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 325:897-905
19. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM 1986 Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) 24:699-713
20. de Herder WW, Lamberts SW 1999 Tumor localization: the ectopic ACTH syndrome. J Clin Endocrinol Metab 84:1184-1185
21. Montravers F, Grahek D, Kerrou K, Ruszniewski P, de Beco V, Aide N, Gutman F, Grangé JD, Lotz JP, Talbot JN 2006 Can fluorodi- hydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? J Nucl Med 47:1455-1462
22. 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 220:373-380
23. Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams KT, Solis D, Lenders JW, Pacak K 2007 Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 25:2262-2269
24. Tsagarakis S, Christoforaki M, Giannopoulou H, Rondogianni F, Housianakou I, Malagari C, Rontogianni D, Bellenis I, Thalassinos N 2003 A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome. J Clin Endocrinol Metab 88:4754-4758
25. 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol 7:728-734